Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR181A2 host gene (MIR181A2HG) is a long non-coding RNA gene that serves primarily as the host transcript for the microRNA miR-181a-2[3]. The gene itself does not code for a protein, but its expression gives rise to miR-181a-2, which participates in the regulation of gene expression post-transcriptionally by targeting other RNAs through the RNA-induced silencing complex (RISC)[2][3]. While the host gene's biological role is largely defined by its function in miRNA production, its overexpression or alteration may have regulatory effects on cellular signaling and is associated with various disease contexts through its product miR-181a-2[1][2][7]. There is currently no known drug acting directly on MIR181A2HG, and its primary relevance as a target comes from the functional consequences of the miRNAs it hosts rather than the lncRNA itself[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR181A2 host gene (non-protein coding) (MIR181A2HG).